|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Altekruse SF, McGlynn KA and Reichman ME:
Hepatocellular carcinoma incidence, mortality, and survival trends
in the United States from 1975 to 2005. J Clin Oncol. 27:1485–1491.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bruix J, Boix L, Sala M and Llovet JM:
Focus on hepatocellular carcinoma. Cancer Cell. 5:215–219. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lau WY and Lai EC: Hepatocellular
carcinoma: Current management and recent advances. Hepatobiliary
Pancreat Dis Int. 7:237–257. 2008.PubMed/NCBI
|
|
5
|
Blum HE and Moradpour D: Viral
pathogenesis of hepatocellular carcinoma. J Gastroenterol Hepatol.
17(Suppl 3): S413–S420. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pérez-Sánchez C, Gómez-Ferrería MA, de La
Fuente CA, Granadino B, Velasco G, Esteban-Gamboa A and Rey-Campos
J: FHX, a novel fork head factor with a dual DNA binding
specificity. J Biol Chem. 275:12909–12916. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pérez-Sánchez C, Arias-de-la-Fuente C,
Gómez-Ferrería MA, Granadino B and Rey-Campos J: FHX.L and FHX.S,
two isoforms of the human fork-head factor FHX (FOXJ2) with
differential activity. J Mol Biol. 301:795–806. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Choi VM, Harland RM and Khokha MK:
Developmental expression of FOXJ1.2, FOXJ2 and FOXQ1 in xenopus
tropicalis. Gene Expr Patterns. 6:443–447. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wijchers PJ, Hoekman MF, Burbach JP and
Smidt MP: Identification of forkhead transcription factors in
cortical and dopaminergic areas of the adult murine brain. Brain
Res. 1068:23–33. 2006. View Article : Google Scholar
|
|
10
|
Kehn K, Berro R, Alhaj A, Bottazzi ME, Yeh
WI, Klase Z, Van Duyne R, Fu S and Kashanchi F: Functional
consequences of cyclin D1/BRCA1 interaction in breast cancer cells.
Oncogene. 26:5060–5069. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang Y, Yang S, Ni Q, He S, Zhao Y, Yuan
Q, Li C, Chen H, Zhang L, Zou L, et al: Overexpression of forkhead
box J2 can decrease the migration of breast cancer cells. J Cell
Biochem. 113:2729–2737. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Qiu X, Ji B, Yang L, Huang Q, Shi W, Ding
Z, He X, Ban N, Fan S, Zhang J and Tian Y: The role of FOXJ2 in the
migration of human glioma cells. Pathol Res Pract. 211:389–397.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kudo M: Hepatocellular carcinoma 2009 and
beyond: From the surveillance to molecular targeted therapy.
Oncology. 75(Suppl 1): S1–S12. 2008. View Article : Google Scholar
|
|
14
|
Patel A and Sun W: Molecular targeted
therapy in hepatocellular carcinoma: From biology to clinical
practice and future. Curr Treat Options Oncol. 15:380–394. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsuchiya N, Sawada Y, Endo I, Saito K,
Uemura Y and Nakatsura T: Biomarkers for the early diagnosis of
hepatocellular carcinoma. World J Gastroenterol. 21:10573–10583.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kaufmann E and Knöchel W: Five years on
the wings of fork head. Mech Dev. 57:3–20. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hannenhalli S and Kaestner KH: The
evolution of fox genes and their role in development and disease.
Nat Rev Genet. 10:233–240. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Carlsson P and Mahlapuu M: Forkhead
transcription factors: Key players in development and metabolism.
Dev Biol. 250:1–23. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jonsson H and Peng SL: Forkhead
transcription factors in immunology. Cell Mol Life Sci. 62:397–409.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Benayoun BA, Caburet S and Veitia RA:
Forkhead transcription factors: Key players in health and disease.
Trends Genet. 27:224–232. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kaneda H, Arao T, Tanaka K, Tamura D,
Aomatsu K, Kudo K, Sakai K, De Velasco MA, Matsumoto K, Fujita Y,
et al: FOXQ1 is overexpressed in colorectal cancer and enhances
tumorigenicity and tumor growth. Cancer Res. 70:2053–2063. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lin L, Miller CT, Contreras JI, Prescott
MS, Dagenais SL, Wu R, Yee J, Orringer MB, Misek DE, Hanash SM, et
al: The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1),
on chromosome band 14q13 is amplified and overexpressed in
esophageal and lung adenocarcinomas. Cancer Res. 62:5273–5279.
2002.PubMed/NCBI
|
|
23
|
Banham AH, Connors JM, Brown PJ, Cordell
JL, Ott G, Sreenivasan G, Farinha P, Horsman DE and Gascoyne RD:
Expression of the FOXP1 transcription factor is strongly associated
with inferior survival in patients with diffuse large B-cell
lymphoma. Clin Cancer Res. 11:1065–1072. 2005.PubMed/NCBI
|
|
24
|
Schuster MB and Porse BT: C/EBPalpha: A
tumour suppressor in multiple tissues? Biochim Biophys Acta.
1766:88–103. 2006.PubMed/NCBI
|
|
25
|
Barrans SL, Fenton JA, Banham A, Owen RG
and Jack AS: Strong expression of FOXP1 identifies a distinct
subset of diffuse large B-cell lymphoma (DLBCL) patients with poor
outcome. Blood. 104:2933–2935. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Banham AH, Beasley N, Campo E, Fernandez
PL, Fidler C, Gatter K, Jones M, Mason DY, Prime JE, Trougouboff P,
et al: The FOXP1 winged helix transcription factor is a novel
candidate tumor suppressor gene on chromosome 3p. Cancer Res.
61:8820–8829. 2001.PubMed/NCBI
|
|
27
|
Chen HW, Huang XD, Li HC, He S, Ni RZ,
Chen CH, Peng C, Wu G, Wang GH, Wang YY, et al: Expression of FOXJ1
in hepatocellular carcinoma: Correlation with patients' prognosis
and tumor cell proliferation. Mol Carcinog. 52:647–659. 2013.
View Article : Google Scholar
|
|
28
|
Lee JS, Chu IS, Heo J, Calvisi DF, Sun Z,
Roskams T, Durnez A, Demetris AJ and Thorgeirsson SS:
Classification and prediction of survival in hepatocellular
carcinoma by gene expression profiling. Hepatology. 40:667–676.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Obama K, Ura K, Li M, Katagiri T, Tsunoda
T, Nomura A, Satoh S, Nakamura Y and Furukawa Y: Genome-wide
analysis of gene expression in human intrahepatic
cholangiocarcinoma. Hepatology. 41:1339–1348. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Granadino B, Arias-de-la-Fuente C,
Pérez-Sánchez C, Párraga M, López-Fernández LA, del Mazo J and
Rey-Campos J: FHX (FOXJ2) expression is activated during
spermatogenesis and very early in embryonic development. Mech Dev.
97:157–160. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen X, Cao X, Tao G, Cao Z, Wang S, Zhou
F, Xie W, Zhao P, Zhang Z and Cui Z: FOXJ2 expression in rat spinal
cord after injury and its role in inflammation. J Mol Neurosci.
47:158–165. 2012. View Article : Google Scholar : PubMed/NCBI
|
